TNYA - Tenaya Therapeutics, Inc.

Across the last three months, Tenaya Therapeutics, Inc.'s insiders have reduced their positions by a net 29,656 shares worth roughly $21K.

TNYA sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Ali Faraz	539.8K	-	-
Other	Tingley Whittemore	263.1K	-	-
VP	Higa Tomohiro	118.3K	$93.8K	-
10%	Column Group III Gp, LP	0	-	-

Buys and sells only

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Aug 17, 2026	Ali Faraz60	Chief Executive Officer	Sell	22,232	$0.71	$15,778.45	-5.1%	-	-
Aug 17, 2026	Tingley Whittemore61	Chief Medical Officer	Sell	7,424	$0.71	$5,269.56	-3.4%	-	-
May 18, 2026	Tingley Whittemore61	Chief Medical Officer	Sell	3,121	$0.79	$2,476.83	-1.4%	-10.6%	-
May 18, 2026	Higa Tomohiro	SVP, Finance	Sell	1,485	$0.79	$1,177.90	-1.2%	-10.6%	-
May 18, 2026	Ali Faraz60	Chief Executive Officer	Sell	3,390	$0.79	$2,689.63	-0.8%	-10.6%	-
Feb 25, 2026	Column Group III Gp, LP77	10% Owner	Sell	4,170,266	$0.57	$2,380,189.07	-100%	+29.9%	-
Feb 23, 2026	Column Group III Gp, LP77	10% Owner	Sell	829,734	$0.61	$504,787.24	-27.3%	+33.0%	-
Feb 17, 2026	Tingley Whittemore61	Chief Medical Officer	Sell	5,160	$0.64	$3,318.72	-2.3%	+24.0%	-
Feb 17, 2026	Higa Tomohiro	SVP, Finance	Sell	3,469	$0.64	$2,231.35	-2.8%	+24.0%	-
Feb 17, 2026	Ali Faraz60	Chief Executive Officer	Sell	14,862	$0.64	$9,556.66	-3.2%	+24.0%	-